Societe des Produits Nestle S.A. 4
4 · Aimmune Therapeutics, Inc. · Filed Oct 15, 2020
Insider Transaction Report
Form 4
Societe des Produits Nestle S.A.
10% Owner
Transactions
- Purchase
Common Stock
2020-10-13$34.50/sh+43,435,583$1,498,527,614→ 43,435,583 total(indirect: See footnote) - Purchase
Common Stock
2020-10-13$34.50/sh+10,681,704$368,518,788→ 23,408,817 total(indirect: See footnote)
Holdings
- 12,727,113
Common Stock
- 525,634
Series A Preferred Stock
Footnotes (3)
- [F1]All of the shares were cancelled on October 13, 2020 pursuant to the terms of that certain Agreement and Plan of Merger, dated as of August 29, 2020 (the "Merger Agreement"), by and among Societe des Produits Nestle S.A. ("SPN"), SPN MergerSub, Inc., a wholly owned subsidiary of SPN ("Merger Sub"), and Aimmune Therapeutics, Inc. ("Aimmune"). Following effectiveness of the merger provided for in the Merger Agreement, SPN owns 100 shares of the common stock of Aimmune, which became a wholly owned subsidiary of SPN as a result of such merger, which represents all of the outstanding shares of common stock of Aimmune.
- [F2]Shares acquired by Merger Sub, upon acceptance of all shares validly tendered and not validly withdrawn pursuant to the tender offer by Merger Sub and SPN, pursuant to the Merger Agreement, for any and all outstanding shares of Aimmune common stock pursuant to that certain Offer to Purchase dated September 14, 2020.
- [F3]Shares acquired pursuant to the merger provided for in the Merger Agreement.